Abiraterone

This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.

Automatically generated on July 6, 2024.

Return to the list of Patented Medicine Litigation page.

ZYTIGA – Janssen Inc. (NOC Search)

Patents:

2661422: JAMP, PHARMASCIENCE, TEVA, SANDOZ, , APOTEX, REDDY
2661442: REDDY, PHARMASCIENCE

Unknown/Other

PM(NOC) – T-1285-20
Correction of Patent Office Records – T-1495-17

APOTEX

Section 8 – T-607-21 (2022 FC 1477, 2022 FC 1476)
Other – 19-A-20
PM(NOC) – A-267-20 (2022 FCA 185) – A-38-21 – A-437-19 (2021 FCA 45) – T-1661-17 (2019 FC 1355) – T-84-19 (2021 FC 3)

JAMP

PM(NOC) – T-989-20

PHARMASCIENCE

PM(NOC) – T-182-19 (2021 FC 5, 2021 FC 7) – T-1893-19 (2021 FC 6)
Appeal – A-36-21 (2022 FCA 184)
Section 8 – T-732-22 (2024 FC 335, 2024 FC 440)

REDDY

Section 8 – T-1168-21 (2022 FC 1473, 2022 FC 1672, 2023 FC 216, 2023 FC 448)
Appeal – A-37-21
PM(NOC) – T-978-19 (2021 FC 4)

SANDOZ

PM(NOC) – T-181-19

TEVA

PM(NOC) – T-1503-17 – T-1504-17

Return to the Patented Medicine Litigation page.

Canadian Intellectual Property